Novel approaches to augment adeno-associated virus type-2 endocytosis and transduction

Virus Research

Volumn 104, Issue 1, 2004, Pages 51-59

  Sanlioglu, Ahter D ^a   Karacay, Bahri ^a,b   Benson, Peter K ^b   Engelhardt, John F ^b   Sanlioglu, Salih ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Adeno associated virus; Endocytosis; Gene therapy; PDTC; Rac 1

Indexed keywords

DNA; MUTANT PROTEIN; PYRROLIDINE DERIVATIVE; PYRROLIDINEDITHIOCARBONATE; RAC1 PROTEIN; TOXIC SUBSTANCE; UNCLASSIFIED DRUG;

ADENO ASSOCIATED VIRUS; ARTICLE; CELL ACTIVITY; ENDOCYTOSIS; EVALUATION; GENOTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS RECOMBINANT; VIRUS STRAIN;

ACTIVE TRANSPORT, CELL NUCLEUS; DEPENDOVIRUS; ENDOCYTOSIS; GENE CONVERSION; HELA CELLS; HUMANS; TRANSDUCTION, GENETIC;

ADENO-ASSOCIATED VIRUS; ADENO-ASSOCIATED VIRUS 2;

EID: 2642558643     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2004.03.002     Document Type: Article

References (42)

1. Alexander I.E., Russell D.W., Miller A.D. DNA-damaging agents greatly increase the transduction of nondividing cells by adeno-associated virus vectors. J. Virol. 68:1994;8282-8287
2. Bennett J., Duan D., Engelhardt J.F., Maguire A.M. Real-time, noninvasive in vivo assessment of adeno-associated virus-mediated retinal transduction. Invest. Ophthalmol. Vis. Sci. 38:1997;2857-2863
3. Clark K.R., Liu X., McGrath J.P., Johnson P.R. Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses. Hum. Gene Ther. 10:1999;1031-1039
4. Cucchiarini M., Ren X.L., Perides G., Terwilliger E.F. Selective gene expression in brain microglia mediated via adeno-associated virus type 2 and type 5 vectors. Gene Ther. 10:2003;657-667
5. Duan D., Fisher K.J., Burda J.F., Engelhardt J.F. Structural and functional heterogeneity of integrated recombinant AAV genomes. Virus Res. 48:1997;41-56
6. Duan D., Li Q., Kao A.W., Yue Y., Pessin J.E., Engelhardt J.F. Dynamin is required for recombinant adeno-associated virus type 2 infection. J. Virol. 73:1999;10371-10376
7. Duan D., Sharma P., Yang J., Yue Y., Dudus L., Zhang Y., Fisher K.J., Engelhardt J.F. Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long term episomal persistence in muscle. J. Virol. 72:1998;8568-8577
8. Duan D., Yue Y., Yan Z., Yang J., Engelhardt J.F. Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus. J. Clin. Invest. 105:2000;1573-1587
9. Engelhardt J.F., Simon R.H., Yang Y., Zepeda M., Weber-Pendleton S., Doranz B., Grossman M., Wilson J.M. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: biological efficacy study. Hum. Gene Ther. 4:1993a;759-769
10. Engelhardt J.F., Yang Y., Stratford-Perricaudet L.D., Allen E.D., Kozarsky K., Perricaudet M., Yankaskas J.R., Wilson J.M. Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1-deleted adenoviruses. Nat. Genet. 4:1993b;27-34
11. Ferrari F.K., Samulski T., Shenk T., Samulski R.J. Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J. Virol. 70:1996;3227-3234
12. Fisher K.J., Gao G.P., Weitzman M.D., DeMatteo R., Burda J.F., Wilson J.M. Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J. Virol. 70:1996;520-532
13. Fisher K.J., Jooss K., Alston J., Yang Y., Haecker S.E., High K., Pathak R., Raper S.E., Wilson J.M. Recombinant adeno-associated virus for muscle directed gene therapy. Nat. Med. 3:1997;306-312
14. Hansen J., Qing K., Kwon H.J., Mah C., Srivastava A. Impaired intracellular trafficking of adeno-associated virus type 2 vectors limits efficient transduction of murine fibroblasts. J. Virol. 74:2000;992-996
15. Hauck B., Xiao W. Characterization of tissue tropism determinants of adeno-associated virus type 1. J. Virol. 77:2003;2768-2774
16. Hirt B. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26:1967;365-369
17. Joneson T., Bar-Sagi D. A Rac1 effector site controlling mitogenesis through superoxide production. J. Biol. Chem. 273:1998;17991-17994
18. Kaplitt M.G., Leone P., Samulski R.J., Xiao X., Pfaff D.W., O'Malley K.L., During M.J. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat. Genet. 8:1994;148-154
19. Kim K.S., Takeda K., Sethi R., Pracyk J.B., Tanaka K., Zhou Y.F., Yu Z.X., Ferrans V.J., Bruder J.T., Kovesdi I., Irani K., Goldschmidt-Clermont P., Finkel T. Protection from reoxygenation injury by inhibition of rac1. J. Clin. Invest. 101:1998;1821-1826
20. Lai C.M., Lai Y.K., Rakoczy P.E. Adenovirus and adeno-associated virus vectors. DNA Cell Biol. 21:2002;895-913
21. Lee R., Beauparlant P., Elford H., Ponka P., Hiscott J. Selective inhibition of l kappaB alpha phosphorylation and HIV-1 LTR-directed gene expression by novel antioxidant compounds. Virology. 234:1997;277-290
22. Musonda C.A., Chipman J.K. Quercetin inhibits hydrogen peroxide (H2O2)-induced NF-kappaB DNA binding activity and DNA damage in HepG2 cells. Carcinogenesis. 19:1998;1583-1589
23. Pracyk J.B., Tanaka K., Hegland D.D., Kim K.S., Sethi R., Rovira I.I., Blazina D.R., Lee L., Bruder J.T., Kovesdi I., Goldshmidt-Clermont P.J., Irani K., Finkel T. A requirement for the rac1 GTPase in the signal transduction pathway leading to cardiac myocyte hypertrophy. J. Clin. Invest. 102:1998;929-937
24. Qing K., Khuntirat B., Mah C., Kube D.M., Wang X.S., Ponnazhagan S., Zhou S., Dwarki V.J., Yoder M.C., Srivastava A. Adeno-associated virus type 2-mediated gene transfer: correlation of tyrosine phosphorylation of the cellular single-stranded D sequence-binding protein with transgene expression in human cells in vitro and murine tissues in vivo. J. Virol. 72:1998;1593-1599
25. Qing K., Mah C., Hansen J., Zhou S., Dwarki V., Srivastava A. Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat. Med. 5:1999;71-77
26. Qing K., Wang X.S., Kube D.M., Ponnazhagan S., Bajpai A., Srivastava A. Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression. Proc. Natl. Acad. Sci. U.S.A. 94:1997;10879-10884
27. Russell D.W., Alexander I.E., Miller A.D. DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors. Proc. Natl. Acad. Sci. U.S.A. 92:1995;5719-5723
28. Sanlioglu S., Benson P.K., Yang J., Atkinson E.M., Reynolds T., Engelhardt J.F. Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by rac1 and phosphatidylinositol-3 kinase activation. J. Virol. 74:2000;9184-9196
29. Sanlioglu S., Duan D., Engelhardt J.F. Two independent molecular pathways for recombinant adeno-associated virus genome conversion occur after UV-C and E4orf6 augmentation of transduction. Hum. Gene Ther. 10:1999;591-602
30. Sanlioglu S., Engelhardt J. Cellular redox state alters recombinant adeno-associated virus transduction through tyrosine phosphatase pathways. Gene Ther. 6:1999;1427-1437
31. Sanlioglu S., Monick M.M., Luleci G., Hunninghake G.W., Engelhardt J.F. Rate limiting steps of AAV transduction and implications for human gene therapy. Curr. Gene Ther. 1:2001a;137-147
32. Sanlioglu S., Williams C.M., Samavati L., Butler N.S., Wang G., McCray P.B. Jr., Ritchie T.C., Hunninghake G.W., Zandi E., Engelhardt J.F. Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor-alpha secretion through IKK regulation of NF-kappa B. J. Biol. Chem. 276:2001b;30188-30198
33. Schreck R., Grassmann R., Fleckenstein B., Baeuerle P.A. Antioxidants selectively suppress activation of NF-kappa B by human T-cell leukemia virus type I tax protein. J. Virol. 66:1992;6288-6293
34. Smith A.D., Collaco R.F., Trempe J.P. Enhancement of recombinant adeno-associated virus type 2-mediated transgene expression in a lung epithelial cell line by inhibition of the epidermal growth factor receptor. J. Virol. 77:2003;6394-6404
35. Sulciner D.J., Irani K., Yu Z.X., Ferrans V.J., Goldschmidt-Clermont P., Finkel T. rac1 regulates a cytokine-stimulated, redox-dependent pathway necessary for NF-kappaB activation. Mol. Cell Biol. 16:1996;7115-7121
36. Summerford C., Bartlett J.S., Samulski R.J. AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection. Nat. Med. 5:1999;78-82
37. Summerford C., Samulski R.J. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J. Virol. 72:1998;1438-1445
38. Toporik A., Gorzalczany Y., Hirshberg M., Pick E., Lotan O. Mutational analysis of novel effector domains in Rac1 involved in the activation of nicotinamide adenine dinucleotide phosphate (reduced) oxidase. Biochemistry. 37:1998;7147-7156
39. Xiao X., Li J., Samulski R.J. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol. 70:1996;8098-8108
40. Yakinoglu A.O., Heilbronn R., Burkle A., Schlehofer J.R., zur Hausen H. DNA amplification of adeno-associated virus as a response to cellular genotoxic stress. Cancer Res. 48:1988;3123-3129
41. Yakobson B., Koch T., Winocour E. Replication of adeno-associated virus in synchronized cells without the addition of a helper virus. J. Virol. 61:1987;972-981
42. Zhang X., Rosenstein B.S., Wang Y., Lebwohl M., Wei H. Identification of possible reactive oxygen species involved in ultraviolet radiation-induced oxidative DNA damage. Free Radic. Biol. Med. 23:1997;980-985